Skip to main content

Obesity Markers Linked to Cancer Risk in Barrett’s Esophagus

For patients with Barrett’s esophagus, levels of leptin, high-molecular-weight adiponectin, and insulin resistance correlate with esophageal adenocarcinoma risk, according to a study published in the August issue of Clinical Gastroenterology and Hepatology.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino